胎儿主动脉瓣成形术后主动脉瓣狭窄患者的出生后循环:系统综述与Meta分析
该系统综述与Meta分析纳入7项研究、共266例接受胎儿主动脉瓣成形术(FAV)的主动脉瓣狭窄胎儿,旨在评估术后出生后循环类型。活产儿中双心室循环(BVC)的合并患病率为45.8%(95%CI 39.2-52.4%),单心室循环(UVC)为43.6%(95%CI 33.9-53.8%);技术成功FAV者中BVC为51.9%(95%CI 44.7-59.1%)。作者认为,鉴于缺乏随机临床试验,结果应谨慎解读,目前数据并不提示FAV对实现BVC有真正获益。
要点
- 活产儿中FAV后BVC合并患病率45.8%,UVC为43.6%。
- 技术成功FAV者中BVC为51.9%,UVC为39.8%。
- FAV技术成功合并患病率82.1%,胎儿死亡16.0%。
核心结论
- 活产儿中FAV后BVC率为46%,技术成功FAV者中改善至52%;鉴于缺乏随机临床试验,结果应谨慎解读,目前数据并不提示FAV对实现BVC有真正获益。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南,检索MEDLINE、EMBASE、Web of Science和Cochrane Library,纳入2000至2020年发表的英文原创论文,要求出生后随访至少12个月,最终纳入7项研究、共266例胎儿,采用随机效应模型进行比例Meta分析,使用CASP工具评价文献质量。
诊断标准与关键数值
- 活产儿中BVC合并患病率45.8%(95%CI 39.2-52.4%),UVC合并患病率43.6%(95%CI 33.9-53.8%)。
- 技术成功FAV的活产儿中BVC合并患病率51.9%(95%CI 44.7-59.1%),UVC合并患病率39.8%(95%CI 29.7-50.9%)。
- FAV技术成功合并患病率82.1%(95%CI 74.3-87.9%),胎儿死亡合并患病率16.0%(95%CI 11.2-22.4%)。
- 终止妊娠合并患病率5.7%(95%CI 2.0-15.5%),活产合并患病率78.8%(95%CI 66.5-87.4%),新生儿死亡合并患病率8.7%(95%CI 4.7-15.5%)。
- 姑息治疗合并患病率4.0%(95%CI 1.9-8.4%),婴儿死亡合并患病率10.3%(95%CI 3.6-26.1%)。
临床应用与阅片要点
- 报告FAV后出生后循环时,应区分活产儿整体与技术成功FAV者两个人群,分别给出BVC与UVC比例。
- FAV技术成功合并患病率为82.1%,胎儿死亡为16.0%,咨询时需同时交代手术技术结局与妊娠结局。
- 作者认为,鉴于缺乏随机临床试验,结果应谨慎解读,目前数据并不提示FAV对实现BVC有真正获益。
局限性
- 作者指出,鉴于缺乏随机临床试验,结果应谨慎解读。
- 作者指出,目前数据并不提示FAV对实现BVC有真正获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Fetal aortic valvuloplasty (FAV) has become a treatment option for critical fetal aortic stenosis (AS) with the goal of preserving biventricular circulation (BVC); however, to date, it is unclear how many patients undergoing FAV achieve BVC. The aim of this systematic review and meta-analysis was to investigate the type of postnatal circulation achieved following FAV.
METHODS: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. MEDLINE, EMBASE, Web of Science and the Cochrane Library were searched systematically for studies investigating postnatal circulation in patients with AS following FAV. Eligible for inclusion were original papers in the English language, published from 2000 to 2020, with at least 12 months of follow-up after birth. Review papers, abstracts, expert opinions, books, editorials and case reports were excluded. The titles and abstracts of all retrieved literature were screened, duplicates were excluded and the full texts of potentially eligible articles were obtained and assessed. The primary endpoint was type of postnatal circulation. Additional assessed outcomes included fetal death, live birth, neonatal death (NND), termination of pregnancy (TOP) and technical success of the FAV procedure. The quality of articles was assessed using the Critical Appraisal Skills Programme (CASP) tool. To estimate the overall proportion of each endpoint, meta-analysis of proportions was employed using a random-effects model.
RESULTS: The electronic search identified 579 studies, of which seven were considered eligible for inclusion in the systematic review and meta-analysis. A total of 266 fetuses underwent FAV with median follow-up per study from 12 months to 13.2 years. There were no maternal deaths and only one case of FAV-related maternal complication was reported. Hydrops was present in 29 (11%) patients. The pooled prevalence of BVC and univentricular circulation (UVC) among liveborn patients was 45.8% (95% CI, 39.2-52.4%) and 43.6% (95% CI, 33.9-53.8%), respectively. The pooled prevalence of technically successful FAV procedure was 82.1% (95% CI, 74.3-87.9%), of fetal death it was 16.0% (95% CI, 11.2-22.4%), of TOP 5.7% (95% CI, 2.0-15.5%), of live birth 78.8% (95% CI, 66.5-87.4%), of NND 8.7% (95% CI, 4.7-15.5%), of palliative care 4.0% (95% CI, 1.9-8.4%) and of infant death 10.3% (95% CI, 3.6-26.1%). The pooled prevalence of BVC and UVC among liveborn patients who had technically successful FAV was 51.9% (95% CI, 44.7-59.1%) and 39.8% (95% CI, 29.7-50.9%), respectively.
CONCLUSIONS: This study showed a BVC rate of 46% among liveborn patients with AS undergoing FAV, which improved to 52% when subjects underwent technically successful FAV. Given the lack of randomized clinical trials, results should be interpreted with caution. Currently, data do not suggest a true benefit of FAV for achieving BVC. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Vorisek, Zurakowski, Tamayo, et al. Postnatal circulation in patients with aortic stenosis undergoing fetal aortic valvuloplasty: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022. PMID: 34726817. doi:10.1002/uog.24807
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。